Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 May 9;11(3):465-469.
doi: 10.14336/AD.2020.0422. eCollection 2020 May.

Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease

Pietro Gentile  1 , Aris Sterodimas  2
Affiliations
Editorial

Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease

Pietro Gentile et al. Aging Dis. .

Abstract

A recent and interesting study reported improved respiratory activity after intravenous administration of mesenchymal stem cells (MSCs) into patients affected by coronavirus disease 2019 (COVID-19). These outcomes displayed that intravenous infiltration of MSCs is a safe and efficacy treatment for COVID-19 pneumonia, a severe acute respiratory illness caused by the coronavirus 2 (SARS-CoV-2). Only 7 patients were treated, but with extraordinary results, opening a new strategy in COVID-19 therapy. Currently, no specific therapies against SARS-CoV-2 are available. The MSCs therapy outcomes reported, are striking, as these cells inhibit the over-activation of the immune system, promoting endogenous repair, by improving the lung microenvironment after the SARS-CoV-2 infection. The MSCs could represent an effective, autologous and safe therapy, and therefore, sharing these published results, here is reported the potential use possibilities in COVID-19 of the most common MSCs represented by Adipose Stem Cells (ASCs).

Keywords: Adipocyte secreted exosomal microRNA; Covid-19; adipose derived stem cells; coronavirus; mesenchymal stem cells.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest The authors declare no conflict of interest.

References

    1. Leng Z, Zhu R, Hou W, et al. (2020). Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis, 11:216-228. - PMC - PubMed
    1. Munster VJ, Koopmans M, van Doremalen N, et al. (2020). A novel coronavirus emerging in China - key questions for impact assessment. N Engl J Med, in press. - PubMed
    1. Sohrabi C, Alsafi Z, O'Neill N, et al. (2020). World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19). Int J Surg, pii: S1743-9191(20)30197-7. - PMC - PubMed
    1. Zhou P, Yang XL, Wang XG, et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579:270-273. - PMC - PubMed
    1. Prockop DJ, Oh JY (2012). Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther, 20:14-20. - PMC - PubMed

Publication types

LinkOut - more resources